JaLCDOI | 10.18926/AMO/31977 |
---|---|
FullText URL | fulltext.pdf |
Author | Mikuniya, Takeshi| Kato, Yoshihisa| Kariyama, Reiko| Monden, Koichi| Hikida, Muneo| Kumon, Hiromi| |
Abstract | Ulifloxacin is the active form of the prodrug prulifloxacin and shows a highly potent antipseudomonal activity. In this study, we examined the combined effect of fosfomycin and ulifloxacin against Pseudomonas aeruginosa (P. aeruginosa) growing in a biofilm using a modified Robbins device with artificial urine, and compared it to that of the combination of fosfomycin and ciprofloxacin or levofloxacin. An ATP bioluminescence assay was used to evaluate the antibacterial activity of the agents against sessile cells in a mature biofilm developed on a silicon disk. The total bioactivity of P. aeruginosa growing in a biofilm that had not been fully eradicated by fosfomycin or any of the fluoroquinolones alone at 10 times the MIC decreased after combination treatment with fosfomycin and fluoroquinolones. Morphological changes occurred in a time-dependent fashion; namely, swollen and/or rounding cells emerged within a couple of hours after combination treatment, marking the initial stage in the process leading to the destruction of the biofilms. We could not find any difference among the 3 fluoroquinolones with regard to their synergistic effects when administered with fosfomycin. The combination treatment of fosfomycin and fluoroquinolones with highly potent antipseudomonal activities was effective in eradicating sessile cells of P. aeruginosa in the biofilm and promises to be beneficial against biofilm-associated infectious diseases. |
Keywords | urinary tract infection Pseudomonas aeruginosa biofilm ulifloxacin fosfomycin |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 209 |
End Page | 216 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286954 |
Web of Science KeyUT | 000232835600005 |
JaLCDOI | 10.18926/AMO/31973 |
---|---|
FullText URL | fulltext.pdf |
Author | Edamura, Kohei| Saika, Takashi| Senoh, Takashi| Koizumi, Fumihito| Manabe, Daisuke| Ebara, Shin| Kaku, Haruki| Yokoyama, Teruhiko| Abarzua, Fernando| Nagai, Atsushi| Nasu, Yasutomo| Tsushima, Tomoyasu| Kumon, Hiromi| |
Abstract | This study was undertaken to reveal the trends of prostate cancer and the outcome of treatment modalities for each disease stage in patients in a single institute over a 10-year period. From January 1994 through December 2003, 420 consecutive patients with previously untreated and histologically confirmed prostate cancer were analyzed for annual distributions of disease stages and treatment modalities and for long-term clinical progression-free survival, prostate cancer-specific survival, and prostate-specific antigen (PSA) failure-free survival rates for each stage and treatment modality. Annual trends showed that the number of patients, especially those with clinically localized cancer, increased dramatically. The 5-year disease-specific survival rates for patients with clinically localized disease were 100 percent for all treatment modalities, including hormonal therapy alone. Patients with PSA levels less than 10 ng/ml showed an 81 percent 5-year PSA failure-free survival rate with radical prostatectomy. Stage C patients treated by surgery or radiation-based therapy with concomitant hormonal therapy obtained 93 percent and 100 percent cause-specific survival rates, respectively, and those treated by hormonal therapy alone showed a 79 percent rate. The number of patients with localized prostate cancer was increasing in this decade. While long-term hormonal therapy alone was highly efficient in controlling localized prostate cancer, radical therapies in conjunction with neo-adjuvant hormonal therapy produced better survival rates in cases of locally advanced disease. |
Keywords | prostate carcinoma long-term cohort retrospective outcome |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 195 |
End Page | 199 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286958 |
Web of Science KeyUT | 000232835600003 |
JaLCDOI | 10.18926/AMO/31976 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Tokuyama, Eijirou| Nanba, Yuzaburo| Tsutsui, Tetsuya| Kimata, Yoshihiro| Nakatsuka, Mikiya| Koshima, Isao| Saika, Takashi| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | The first case of sex reassignment surgery (SRS) in our hospital was performed in January 2001; as of February, 2005, 4 cases of MTF-SRS had been performed. In the 2 most recent cases, we used penile and scrotal skin flaps to avoid complications. The depth and width of the new vagina was made to be adequate for sexual intercourse. Future attention should be focused on devising a surgical technique that will help prevent the complications of partial necrosis of the epidermal skin and wound dehiscence. Although ours is only an initial experience, we describe our surgical technique herein. |
Keywords | gender identity disorder sex reassignment surgery male to female transsexual |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-10 |
Volume | volume59 |
Issue | issue5 |
Publisher | Okayama University Medical School |
Start Page | 231 |
End Page | 233 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16286961 |
Web of Science KeyUT | 000232835600008 |
JaLCDOI | 10.18926/AMO/31978 |
---|---|
FullText URL | fulltext.pdf |
Author | Ozawa, Hideo| Nagai, Atsushi| Uematsu, Katsutoshi| Ohmori, Hiroyuki| Kumon, Hiromi| |
Abstract | We report a case in which retroperitoneoscopic pyelolithotomy was the procedure selected to treat a large stone in the upper urinary tract. A 71-year-old woman who had multiple cerebral infarction and dementia was admitted with a persistent high fever unresponsive to antibiotics. The diagnosis was pyelonephritis and urosepsis associated with ureteral calculus. A large calculus(3.0 x 2.0 cm)was found in the left ureter at the L3 level. She underwent nephrostomy of the left side. After the patient's general condition had improved, surgery was performed successfully with an uneventful recovery. The findings in this case confirm that retroperitoneoscopic surgery allows removal of a large stone in a single, minimally invasive procedures. |
Keywords | retroperitoneoscopic pyelolithotomy urinary stone laparoscopic surgery |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-06 |
Volume | volume59 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 109 |
End Page | 112 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049564 |
Web of Science KeyUT | 000230039100006 |
JaLCDOI | 10.18926/AMO/31979 |
---|---|
FullText URL | fulltext.pdf |
Author | Seno, Yuko| Kariyama, Reiko| Mitsuhata, Ritsuko| Monden, Koichi| Kumon, Hiromi| |
Abstract | The potential relationships between biofilm formation and pathogenicity of Enterococcus faecalis in urinary tract infections (UTI) were investigated. Over a 12-year period from 1991 through 2002, a total of 352 E.faecalis isolates were collected from patients with complicated UTI (one isolate per patient) at the urology ward of Okayama University Hospital. We analyzed the prevalence and transferability of genes encoding virulence factors(asa1, esp, cylA, gelE /sprE )and antimicrobial resistance(aac(6') /aph(2'')). The production of biofilm, hemolysin and gelatinase by these isolates was also examined and the associated medical records of patients were retrospectively reviewed. Of 352 E. faecalis isolates, 315 possessed and/or genes. Of the 63 hemolysin- and 167 gelatinase-producing isolates, 59 and 94 isolates, respectively, possessed both asa1 and esp genes. E. faecalis isolates with both asa1 and esp genes formed biofilms at significantly higher rates than those with neither gene (P=0.038). The genes encoding asa1, cylA , and aac(6') /(aph(2'') were transferable and appeared to have accumulated in these isolates. The E. faecalis isolates possessing asa1 and/or esp genes were found from both catheter-related or -unrelated UTI. Our study indicates that E. faecalis isolates that have accumulated virulence genes are apt to form persistent biofilms in the urinary tracts. |
Keywords | Enterococcus faecalis urinary tract infection biofilm formation pathogenicity gene transfer |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-06 |
Volume | volume59 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 79 |
End Page | 87 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049560 |
Web of Science KeyUT | 000230039100002 |
JaLCDOI | 10.18926/AMO/31964 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Nasu, Yasutomo| Watanabe, Masami| Kusumi, Norihiro| Tsuboi, Hiromu| Kumon, Hiromi| |
Abstract | We investigated the usefulness of one-stage urethroplasty by the parameatal foreskin flap method (OUPF procedure), which is useful for repairing all types of hypospadias. Between June 1992 and March 2001, the OUPF procedure was performed on 18 patients with hypospadias: 10 patients with distal and 8 with proximal hypospadias. The follow-up periods ranged from 33-75 months, with an average of 52 months. The duration of surgery, the catheter indwelling period, and the postoperative complications of each patient were analyzed. The median age of the patients at the time of surgery was 3 years and 8 months. The length of surgery for OUPF II ranged from 150-230 min (average 186 min), and from 190-365 min (average 267 min) for OUPF IV. Postoperative complications were confirmed in 3 of the 18 patients (16.6%). Two patients had fistulas, and one had a meatal regression. The fistulas were successfully closed by the simple multilayered closure method. After adopting DuoDerm dressings instead of elastic bandages for protection of the wound, no fistulization occurred. DuoDerm dressings are useful in the healing of wounds without complications. To date, the longest follow-up period has been 75 months, and during that time there have been no late complications such as urethral stenosis or penile curvature. OUPF is a useful method in the treatment of hypospadias with a low incidence of early and late complications. |
Keywords | hypospadias one-stageure throplasty OUPF DuoDerm dressings |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2005-04 |
Volume | volume59 |
Issue | issue2 |
Publisher | Okayama University Medical School |
Start Page | 45 |
End Page | 48 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 16049554 |
Web of Science KeyUT | 000228590000002 |
Author | 門田 晃一| 公文 裕巳| |
---|---|
Published Date | 2005-01-31 |
Publication Title | 岡山医学会雑誌 |
Volume | volume116 |
Issue | issue3 |
Content Type | Journal Article |
JaLCDOI | 10.18926/AMO/32084 |
---|---|
FullText URL | fulltext.pdf |
Author | Abarzua, Fernando| Monden, Koichi| Nagai, Atsushi| Nasu, Yasutomo| Kumon, Hiromi| |
Abstract | Ureteroscopy has evolved in many aspects, particularly in the flexibility and size of ureteroscopes. We have developed a new detachable access sheath to make ureteroscopic procedures more straight-forward and to reduce possible damage to delicate instruments used in the procedure. |
Keywords | ureteroscopy detachable accesss heath |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2004-08 |
Volume | volume58 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 215 |
End Page | 216 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15551759 |
Web of Science KeyUT | 000223559700006 |
JaLCDOI | 10.18926/AMO/32090 |
---|---|
FullText URL | fulltext.pdf |
Author | Ando, Eiichi| Monden, Koichi| Mitsuhata, Ritsuko| Kariyama, Reiko| Kumon, Hiromi| |
Abstract | Staphylococci have been confirmed to form biofilms on various biomaterials. The purpose of this study was to investigate biofilm formation among methicillin-resistant Staphylococcus aureus (MRSA) isolates from patients with urinary tract infection (UTI) and to assess the relationship between biofilm-forming capacities and virulence determinants/clinical background. Over a 12-year period from 1990 through 2001, a total of 109 MRSA isolates were collected from patients (one isolate per patient) with UTI at the urology ward of Okayama University Hospital. We used the in vitro microtiter plate assay to quantify biofilm formation. We then investigated the presence of several virulence determinants by polymerase chain reaction assay and found eight determinants (tst, sec, hla, hlb, fnbA, clfA, icaA, and agrII) to be predominant among these isolates. Enhanced biofilm formation was confirmed in hla-, hlb-, and fnbA-positive MRSA isolates, both individually and in combination. Upon review of the associated medical records, we concluded that the biofilm-forming capacities of MRSA isolates from catheter-related cases were significantly greater than those from catheter-unrelated cases. The percentage of hla-, hlb-, and fnbA-positive isolates was higher among MRSA isolates from catheter-related cases than those from catheter-unrelated cases. Our studies suggest that MRSA colonization and infection of the urinary tract may be promoted by hla, hlb, and fnbA gene products. |
Keywords | methicillin-resistant Staphylococcus aureus urinary tract infection biofilm formation |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2004-08 |
Volume | volume58 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 207 |
End Page | 214 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15551758 |
Web of Science KeyUT | 000223559700005 |
JaLCDOI | 10.18926/AMO/32106 |
---|---|
FullText URL | fulltext.pdf |
Author | Yokoyama, Teruhiko| Tsugawa, Masaya| Nagai, Atsushi| Kumon, Hiromi| |
Abstract | We retrospectively evaluated the subjective and objective treatment results of transurethral microwave thermotherapy (TUMT) for benign prostatic hyperplasia (BPH) and explored the difference in effectiveness between 30- and 60-min single treatments. From June 1997 through March 2003, 58 men with BPH underwent TUMT using the Targis device. Twenty-seven and 31 patients each received a single treatment of 60 or 30 min, respectively. Evaluations after treatment included a clinical determination of the International Prostate Symptom Score, urodynamic assessments by peak flow rate, and magnetic resonance imaging (MRI). In the 60-min treatment, the symptom score improved significantly, from 17.9 to 9.5 after 2 months. Similarly, there was a significant improvement in peak flow rate, from 6.7 to 11.2 ml/sec after 2 months. In the 30-min treatment, the symptom score also improved significantly, from 18.4 to 13.4 after 2 weeks. Similarly, there was a significant improvement in the peak flow rate, from 6.4 to 11.7 ml/sec after 1 month. MRI imaging showed necrosis of the prostate gland 2 weeks after either treatment. These results demonstrated that both the 60-min and the 30-min treatments were effective for patients with BPH. Moreover, the 30-min treatment led to quicker improvement than the 60-min treatment. Thus, a 30-min TUMT protocol is considered recommendable for this treatment. |
Keywords | prostate benign prostatic hyperplasia microwave thermotherapy MRI |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2004-06 |
Volume | volume58 |
Issue | issue3 |
Publisher | Okayama University Medical School |
Start Page | 151 |
End Page | 156 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15471437 |
Web of Science KeyUT | 000222273300006 |
JaLCDOI | 10.18926/AMO/32115 |
---|---|
FullText URL | fulltext.pdf |
Author | Araki, Tohru| Yokoyama, Teruhiko| Kumon, Hiromi| |
Abstract | We explored the effectiveness of loxoprofen sodium (loxoprofen), which is the most common non-steroidal anti-inflammatory drug (NSAID) in Japan, for patients with benign prostatic hyperplasia (BPH) complaining of nocturia. A total of 93 BPH patients aged 49-84 years were enrolled in the study. These patients had received standard drug therapy with alpha1-blocker for BPH, followed by anticholinergic drugs, hypnotics, tricyclic antidepressants, and/or antiduretic hormone, but they still complained about 2 or more episodes of nocturia. They each took a single 60-mg tablet of loxoprofen prior to sleeping at night for 14 days in addition to their BPH treatments. The effects were assessed by questionnaire before and after treatment as excellent (nocturia disappeared or decreased by 2 or more voids/night), improved (nocturia decreased by 1 void/night), unchanged, or worsened (nocturia increased). Nocturia improved or disappeared in 74.2% of patients: excellent, improved, unchanged, and worsened results were obtained in 37.6%, 36.6%, 21.5%, and 4.3% of patients, respectively. The effects were better in patients whose baseline nocturia was > 2 times than in those with a lesser frequency at enrollment (P = 0.04). Loxoprofen can be an effective and useful treatment option for patients with BPH complaining of refractory nocturia. |
Keywords | nocturia loxoprofen sodium non-steroidal anti-inflammatory drugs (NSAIDs) |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2004-02 |
Volume | volume58 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 45 |
End Page | 49 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 15157011 |
Web of Science KeyUT | 000189271100007 |
JaLCDOI | 10.18926/AMO/32815 |
---|---|
FullText URL | fulltext.pdf |
Author | Saika, Takashi| Tsushima, Tomoyasu| Nasu, Yasutomo| Arata, Ryoji| Kaku, Haruki| Akebi, Naoki| Kusaka, Nobuyuki| Kumon, Hiromi| |
Abstract | The aim of this study was to reveal the clinical features of anterior urethral recurrence in patients with superficial bladder cancer, and to determine the appropriate treatment. Three hundred and three patients with superficial bladder cancer, who were newly diagnosed and initially treated conservatively in our hospital between 1965 and 1990, were followed for at least 5 years and their clinical outcomes were analyzed. Clinical factors, including anterior urethral recurrence, were evaluated statistically regarding tumor progression. Eight patients (2.6%) had anterior urethral recurrence following superficial bladder cancer. Twenty-four patients (7.9%) had tumor progression and 149 (49.2%) had tumor recurrence. In a multivariate analysis using a logistic model, anterior urethral recurrence was the most important factor, followed by histological grade. Four of 5 patients who were treated for anterior urethral recurrent tumors by transurethral resection showed progression and died of the cancer within one year. Two of the remaining three patients who underwent radical cysto-urethrectomy at the time of anterior urethral recurrence survived. Anterior urethral recurrence following superficial bladder cancer is a predictor for rapid subsequent malignant progression. Once there is anterior urethral recurrence, radical intensive therapy, including radical cysto-urethrectomy, should be carried out immediately. |
Keywords | superficial bladder cancer anterior urehral recurrence prognosis predictor |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2003-12 |
Volume | volume57 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 293 |
End Page | 297 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 14726966 |
Web of Science KeyUT | 000187556500004 |
JaLCDOI | 10.18926/AMO/31693 |
---|---|
FullText URL | fulltext.pdf |
Author | Yokoyama, Teruhiko| Kumon, Hiromi| Smith, Christopher P| Somogyi, George T| Chancellor, Michael B| |
Abstract | Tremendous excitement has been generated by the use of botulinum toxin for the treatment of various types of urethral and bladder dysfunction over the past several years. Botulinum toxin is the most lethal naturally occurring toxin known to mankind. Why, then, would an urologist want to use this agent to poison the bladder or urethral sphincter? In this review article we will examine the mechanisms underlying the effects of botulinum toxin treatment. We will discuss the current use of this agent within the urologic community and will provide perspectives on future targets of botulinum toxin. |
Keywords | botulinum toxin urethra bladder |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2002-12 |
Volume | volume56 |
Issue | issue6 |
Publisher | Okayama University Medical School |
Start Page | 271 |
End Page | 277 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 12685855 |
Web of Science KeyUT | 000179959000001 |
Author | 那須 保友| 公文 裕巳| |
---|---|
Published Date | 2002-09-30 |
Publication Title | 岡山医学会雑誌 |
Volume | volume114 |
Issue | issue2 |
Content Type | Journal Article |
JaLCDOI | 10.18926/AMO/31681 |
---|---|
FullText URL | fulltext.pdf |
Author | Iguchi, Hiroki| Watanabe, Masami| Kamitani, Akihiro| Nagai, Atsushi| Hosoya, Osamu| Tsutsui, Kimiko| Kumon, Hiromi| |
Abstract | Dynamin is a protein essential to endocytosis. Dynamin 2, a dynamin isoform, is expressed most intensely in testicular tissue; however, precise localization has never been studied. Therefore, we investigated the expression of dynamin 2 in rat testicular tissue using immunohistochemical methods, and discuss here the physiological function of this protein. Testicular tissues were obtained from Wistar rats at 10, 21 and 63 days of age. Immunohistochemistrical examination and Western blot analysis were conducted using dynamin 2 specific antibody. Western blot analysis showed that expression in 21- and 63-day-old rats was more intense than that in 10-day-old rats. Dynamin 2 expression was observed using immunohistochemical method in the seminiferous tubules of all rats. In the 63-day-old rats, the expression was intense, especially in spermatids in the earlier maturation stages and in spermatocytes, and was observed in Sertoli cells. However, in spermatids, the expression gradually declined as spermatids matured to spermatozoa. In the 21-day-old rats, the expression was evident in spermatocytes and Sertoli cells, but that in the 10-day-old rats was weak. Intense expression of dynamin 2 during spermatogenesis suggests that this protein plays an important role in this process. |
Keywords | dynamin 2 endocytosis spermatogenesis |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2002-08 |
Volume | volume56 |
Issue | issue4 |
Publisher | Okayama University Medical School |
Start Page | 205 |
End Page | 209 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 12199526 |
Web of Science KeyUT | 000177382600006 |
Author | 新島 端夫| 田中 啓幹| 公文 裕巳| |
---|---|
Published Date | 2002-05-30 |
Publication Title | 岡山医学会雑誌 |
Volume | volume114 |
Issue | issue1 |
Content Type | Others |
JaLCDOI | 10.18926/AMO/31722 |
---|---|
FullText URL | fulltext.pdf |
Author | Nagai, Atsushi| Nasu, Yasutomo| Shirasaki, Yoshinori| Iguchi, Hiroki| Arata, Ryouji| Tsugawa, Masaya| Tsushima, Tomoyasu| Kumon, Hiromi| |
Abstract | We performed laparoscopic prostatectomy in seven cases with organ-confined prostate cancer. In 6 cases, the surgery was completed successfully and the mean operative time was 424 min. Volume of blood loss was 200 to 3,200 ml and catheterization lasted 6 to 37 days. No major complications were observed in 6 of the cases. In one case, open surgical conversion was necessary mainly due to a bladder injury. Although these were the first cases of laparoscopic prostatectomy in our institution, the technical difficulty and complexity of the surgery were moderate. We believe that laparoscopic radical prostatectomy will become a standard option for the treatment of organ-confined prostate cancer. |
Keywords | prosatatic cancer laparoscopy prostatectomy |
Amo Type | Article |
Publication Title | Acta Medica Okayama |
Published Date | 2002-02 |
Volume | volume56 |
Issue | issue1 |
Publisher | Okayama University Medical School |
Start Page | 51 |
End Page | 52 |
ISSN | 0386-300X |
NCID | AA00508441 |
Content Type | Journal Article |
language | English |
File Version | publisher |
Refereed | True |
PubMed ID | 11873945 |
Web of Science KeyUT | 000174031300009 |
Author | 永井 敦| 井口 裕樹| 津島 知靖| 公文 裕巳| |
---|---|
Published Date | 2001-12-31 |
Publication Title | 岡山医学会雑誌 |
Volume | volume113 |
Issue | issue3 |
Content Type | Journal Article |
Author | 黒瀬 恭平| 渡辺 雄一| 永井 敦| 公文 裕巳| |
---|---|
Published Date | 2001-12-31 |
Publication Title | 岡山医学会雑誌 |
Volume | volume113 |
Issue | issue3 |
Content Type | Journal Article |
Author | Satoh, Shuhei| Kitagawa, Takahiro| Satoh, Nobuo| Togami, Izumi| Kimoto, Shin| Hiraki, Yoshio| Uno, Satoru| Kumon, Hiromi| Ohmori, Hiroyuki| |
---|---|
Published Date | 1991 |
Publication Title | 岡山医学会雑誌 |
Volume | volume103 |
Issue | issue11-12 |
Content Type | Journal Article |